HAUSP-p53 interaction and uses thereof

Details HAUSP-p53 interaction and uses thereof HAUSP-p53 interaction and uses thereof

2002-03-30

2008-09-16

Fetterolf, Brandon J (Department: 1642)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C435S006120, C435S007100, C435S007230

Reexamination Certificate

active

07425538

ABSTRACT:
The present invention provides methods for determining whether a subject has neoplasia, methods for assessing the efficacy of therapy to treat neoplasia in a subject, methods for assessing the prognosis of a subject who has neoplasia, and methods for treating neoplasia in a subject in need of treatment. The present invention further provides a kit for use in detecting neoplasia. Additionally, the present invention provides a pharmaceutical composition, comprising a modulator of HAUSP expression or a HAUSP protein and a pharmaceutically acceptable carrier. Also provided is a method for deubiquitinating p53 in a cell. The present invention is further directed to a method for identifying an agent that is reactive with p53, and the agent identified by this method. Furthermore, the present invention provides a method for treating a p53-associated condition in a subject in need of treatment. The present invention is also directed to a complex comprising p53 and HAUSP, and a mutant protein comprising the HAUSP amino acid sequence, in which Ser is substituted for Cys at amino acid residue 223. Finally, the present invention provides a transgenic non-human animal whose genome comprises a disruption in its endogenous HAUSP gene.

REFERENCES:
patent: 6083709 (2000-07-01), Reynolds et al.
patent: 2004/0265931 (2004-12-01), Gu et al.
patent: WO 01/32696 (2001-05-01), None
patent: WO 0132696 (2001-05-01), None
Kashuba et al. (FEBS Letters 1997, 419; 181-185).
Ovaa et al. (PNAS 2004; 101: 2253-2258).
Muratani et al. (Nat. Cell Bio. 2002; 4: 106-110).
E. Appella and CW Anderson,Signaling to p53: Breaking the Posttranslational Modification Code, Pathol. Biol. (Paris) 48:227-45 (Apr. 2000) (abstract only).
Margaret Ashcroft and Karen H. Vousden,Regulation of p53 Stability, Oncogene, 18:7637-43 (Dec. 1999) (abstract only).
Margaret Ashcroft et al.,Regulation of p53 Function and Stability by Phophorylation, Mol. Cell Biol., 19:1751-58 (Mar. 1999).
Margaret Ashcroft et al,Stress Signals Utilize Multiple Pathways to Stabilize p53, Mol. Cell Biol., 20:3224-33 (May 2000).
Y. Barak et al.,mdm2 Expression is induced by Wild Type p53 Activity, EMBO J., 12:461-68 (Feb. 1993) (abstract only).
Christine Blattner et al.,DNA Damage Induced p53 Stabilization: No Indication for an Involvement of p53 Phosphorylation, Oncogene, 18:1723-32 (Mar. 1999) (abstract only).
Vladimir Botchkarev et al.,p53 is Essential for Chemotherapy-induced Hair Loss, Cancer Res., 60:5002-06 (Sep. 2000).
Chin Ha Chung and Sung Hee Baek,Deubiquitinating Enzymes: Their Diversity and Emerging Roles, Biochem. Biophys. Res. Commun., 266:633-40 (Dec. 1999) (abstract only).
A. D'Andrea and D. Pellman,Deubiquitinating Enzymes: A New Class of Biological Regulators, Crit. Rev. Biochem. Mol. Biol., 33(5):337-52 (1998) (abstract only).
L.A. Donehower et al.,Mice Deficient for p53 are Developmentally Normal but Susceptible to Spontaneous Tumors, Nature, 356:215-21 (Mar. 1992) (abstract only).
Nicolas Dumaz and David W. Meek,Serine 15 Phosphorylation Stimulates p53 Transactivation but Does Not Directly Influence Interaction with HDM2, EMBO J., 18:7002-10 (1999).
W.S. el-Deiry et al.,WAF1, A Potential Mediator of p53 Tumor Suppression, Cell, 75:817-825 (Nov. 1993) (abstract only).
Roger D. Everett et al.,A Novel Ubiquitin-specific Protease is Dynamically Associated with the PML Nuclear Domain and Binds to a Herpesvirus Regulatory Protein, EMBO J., 16:1519-30 (1997).
D.A. Freedman et al.,Functions of the MDM2 Oncoprotein, Cell Mol. Life Sci., 55:96-107 (Jan. 1999) (abstract only).
Amato J. Giaccia and Michael B. Kastan,The Complexity of p53 Modulation: Emerging Patterns from Divergent Signals, Genes & Dev., 12:2973-83 (1998).
W. Gu et al.,Synergistic Activation of Transcription by CBP and p53, Nature, 387:819-23 (Jun. 1997) (abstract only).
Y. Haupt et al,Mdm2 Promotes the Rapid Degradation of p53, Nature, 387:296-99 (May 1997) (abstract only).
Avram Hershko et al.,The Ubiquitin System, Nat. Med., 6:1073-81 (Oct. 2000).
M. Hollstein et al.,Database of p53 Gene Somatic Mutations in Human Tumors and Cell Lines, Nucleic Acids Res., 22:3551-55 (Sep. 1994) (abstract only).
M. Hollenstein et al.,New Approaches to Understanding p53 Gene Tumor Mutation Spectra, Mutat. Res., 431:199-209 (Dec. 1999) (abstract only).
Reiko Honda et al.,Oncoprotein MDM2 is a Ubiquitin Ligase E3 for Tumor Suppressor p53, FEBS Letters, 420:25-27 (1997).
M. H. Kabbutat et al.,Regulation of p53 Stability by Mdm2, Nature, 387:299-303 (May 1997) (abstract only).
M. B. Kastan et al.,A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective in Ataxia-telangiectasia, Cell, 71:587-97 (Nov. 1992) (abstract only).
Daniel Kornitzer and Aaron Ciechanover,Modes of Regulation of Ubiquitin-mediated Protein Degradation, J. Cell. Phys., 182:1-11 (2000) (abstract only).
D. P. Lane,Cancer. p53, guardian of the genome, Nature, 358:15-16 (Jul. 1992) (abstract only).
J. D. Laney and M. Hochstrasser,Substrate Targeting in the Ubiquitin System, Cell, 97:427-30 (May 1999) (no abstract avail).
A.J. Levine, p53,The Cellular Gatekeeper for Growth and Division, Cell 88:323-31 (Feb. 1997) (no abstract available).
J. Luo et al.,Deacetylation of p53 Modulates its Effect on Cell Growth and Apoptosis, Nature, 408:377-81 (Nov. 2000) (abstract only).
J. Luo et al.,Negative Control of p53 by Sir2a Promotes Cell Survival under Stress, Cell, 107:137-48 (Oct. 2001) (abstract only).
K. Nakano and K.H. Vousden,PUMA, A Novel Proapoptic Gene, Is Induced by p53, Molecular Cell, 7:683-94 (Mar. 2001) (abstract only).
E. Oda et al.,Noxa, a BH3-only Member of the Bcl-2 Family and Candidate Mediator of p53-induced Apoptosis, Science, 288:1053-58 (May 2000) (abstract only).
K. Oda et al.,p53AIP1, A Potential Mediator of p53-dependent Apoptosis, and its Regulation by Ser-46-phophorylated p53, Cell, 102:849-62 (Sep. 2000) (abstract only).
K. Okamoto and D. Beach,Cyclin G is a Transcriptional Target of the p53 Tumor Suppressor Protein, EMBO J., 13:4816-22 (Oct. 1994) (abstract only).
Moshe Oren,Regulation of the p53 Tumor Suppressor Protein, J. Biol. Chem., 274, 36031-034 (Dec. 1999).
Carol Prives and Peter A. Hall,The p53 Pathway, J. Pathol., 187:112-26 (1999) (abstract only).
Rodriguez et al.,Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-mediated Degradation, Mol. Cell. Biol., 20:8458-67 (Nov. 2000).
M. Scheffner et al.,The HPV-16 E6 and E6-AP Complex Functions as a Ubiquitin-protein Ligase in the Ubiquitination of p53, Cell, 75:495-505 (Nov. 1993) (abstract only).
Scott E. Seavey et al.,The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 Through a Mechanism Independent of p19ARF, J. Virol., 73:7590-98 (Sep. 1999).
C.J. Sherr and J. D. Weber,The ARF/p53 Pathway, curr. Opin. Genet. Dev., 10:94-99 (Feb. 2000) (abstract only).
S.Y. Shieh et al.,DNA Damage-induced Phosphorylation of p53 Alleviates Inhibition by MDM2, Cell, 91:325-34 (Oct. 1997) (abstract only).
Slingerland and Pagano,Regulation of the Cdk Inhibitor p27 and its Deregulation in Cancer, J. Cell Physi., 183:10-17 (2000) (abstract only).
Dawn Tolbert et al.,p19ARFis Dispensable for Oncogenic Stress-induced p53-mediated Apoptosis and Tumor SuppressionIn Vivo, Mol. Cell Biol., 22:370-77 (Jan. 2002).
B. Vogelstein et al.,Surfing the p53-Network, Nature, 408:307-10 (Nov. 2000) (no abstract avail.).
Keith D. Wilkinson,Ubiquitination and Deubiquitination: Targeting of Proteins for Degradation by the Proteasome, Semin. Cell Dev. Biol., 11:141-48 (Jun. 2000) (abstract only).
X. Wu et al,The p53-mdm-2 Autoregulatory Feedback Loop, Genes Dev., 7:1126-32 (Jul. 1993) (abstract only).
J. Yu et al.,PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells, Molecular Cell, 7:673-82 (Mar. 2001) (abstract only).
Cummins et al., Disruption of HAUSP gene stabilizes p53. Nature 428:1-2 (2004).
Kashuba, V.I., et al., Notl linking/jumping clones of human chromosome 3:mapping of the TFRC, RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumors. FEBS Letters 419 (1997) 181-185.

Affiliated with

Also associated with

Rating

HAUSP-p53 interaction and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HAUSP-p53 interaction and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HAUSP-p53 interaction and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3988373